| Schedule of Earnings Per Share, Basic and Diluted |
|
|
For the Three
Months Ended
November 30,
2020
|
|
For the Six
Months Ended
November 30,
2020
|
Numerator: |
|
|
|
|
Net income |
$ |
1,397,183 |
|
823,046 |
Effect of dilutive securities |
|
175,356 |
|
175,356 |
|
|
|
|
|
Diluted net income |
$ |
1,572,539 |
$ |
998,402 |
|
|
|
|
|
Denominator: |
|
|
|
|
Weighted average common shares outstanding - basic |
|
252,603,584 |
|
167,748,635 |
|
|
|
|
|
Dilutive securities (a): |
|
|
|
|
Series A Preferred |
|
1,177,041,100 |
|
1,177,041,100 |
Series B Preferred |
|
5,499,034,800 |
|
5,499,034,800 |
Convertible notes |
|
1,236,932,052 |
|
1,236,932,052 |
Warrants |
|
1,099,378,215 |
|
1,099,378,215 |
|
|
|
|
|
Weighted average common shares outstanding and assumed conversion diluted |
|
9,264,989,751 |
|
9,180,134,802 |
|
|
|
|
|
Basic net income per common share |
$ |
0.01 |
$ |
0.00 |
|
|
|
|
|
Diluted net income per common share |
$ |
0.00 |
$ |
0.00 |
|
|
|
|
|
(a) - Anti-dilutive securities excluded: |
|
- |
|
- |
|